ATM Is Required for Efficient Recombination between Immunoglobulin Switch Regions by Reina-San-Martin, Bernardo et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
The Journal of Experimental Medicine • Volume 200, Number 9, November 1, 2004 1103–1110
http://www.jem.org/cgi/doi/10.1084/jem.20041162
 
1103
 
ATM Is Required for Efﬁcient Recombination between 
Immunoglobulin Switch Regions
 
Bernardo Reina-San-Martin,
 
1 
 
Hua Tang Chen,
 
2 
 
André Nussenzweig,
 
2
 
and Michel C. Nussenzweig
 
1
 
1
 
Laboratory of Molecular Immunology and Howard Hughes Medical Institute, The Rockefeller University, New York, 
NY 10021
 
2
 
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
 
Abstract
 
Ataxia telangiectasia mutated (ATM) kinase is critical for initiating the signaling pathways that
lead to cell cycle checkpoints and DNA double strand break repair. In the absence of ATM,
humans and mice show a primary immunodeficiency that includes low serum antibody titers,
but the role of ATM in antigen-driven immunoglobulin gene diversification has not been defined.
Here, we show that although ATM is dispensable for somatic hypermutation, it is required for
efficient class switch recombination (CSR). The defect in CSR is not due to alterations in
switch region transcription, accessibility, DNA damage checkpoint protein recruitment, or
short-range intra-switch region recombination. Only long-range inter-switch recombination is
defective, indicating an unexpected role for ATM in switch region synapsis during CSR.
Key words: class switch recombination • somatic hypermutation • activation-induced 
cytidine deaminase • ATM • DNA repair
 
Introduction
 
In mature B cells responding to antigen, antibody genes are
diversified by somatic hypermutation (SHM; 1) and class
switch recombination (CSR; 2, 3). Both of these reac-
tions are initiated by activation-induced cytidine deaminase
(AID; 4, 5), an enzyme that deaminates cytidines in single
stranded DNA (6–13). SHM alters the antigen binding
specificity of antibodies by introducing point mutations in
Ig variable regions (1). CSR is a region-specific deletional
recombination reaction that joins large repetitive switch re-
gion sequences located upstream of each Ig constant region
(2, 3). CSR replaces the upstream constant region (C
 
 
 
)
with a downstream C
 
H 
 
gene (
 
 
 
, 
 
 
 
, or 
 
 
 
), thereby producing
an Ig with a new set of effector functions while retaining
the original antigen-binding specificity (2, 3).
Specific switch regions are targeted for recombination by
cytokine-induced transcription from intronic (I) promoters
located 5
 
  
 
of each switch region. These promoters are essen-
tial for CSR (14–19), possibly because they facilitate switch
region accessibility to AID and expose single stranded DNA
during the transcription reaction (9–13, 20, 21). AID has
been proposed to initiate CSR by creating dU:dG mismatches
that are processed by uracyl-DNA glycosylase (6–8) and
mismatch repair enzymes (22–27) to produce DNA double
strand break (DSB) intermediates. However, the exact mech-
anism by which these lesions are generated remains unclear
(28). Ultimately, DNA breaks occurring in both donor and
acceptor S regions are repaired by nonhomologous end join-
ing (29–32), and the intervening DNA sequences are re-
leased as a circular episome (33–35).
Switch region DNA DSBs become associated with phos-
phorylated histone H2AX (
 
 
 
-H2AX; 32, 36, 37). This
modified histone forms foci at sites of CSR that are be-
lieved to facilitate the focal accumulation of several addi-
tional DNA repair factors (36) like 53BP1, which is re-
quired for CSR (38, 39). Although the role of these foci in
CSR has not been determined, efficient switching requires
H2AX (32, 36, 37).
H2AX is one of many substrates of the phosphatydil-
inositol-3 kinase-like kinase (PIKK) family of proteins that
includes ataxia telangiectasia mutated (ATM), ATM and
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Rad3-related (ATR), and DNA-dependent protein kinase
(DNA-PK; 40). These kinases are the prototype transduc-
ers of the DNA damage signal (40), and DNA-PK (consist-
ing of DNA-PK catalytic subunit [DNA-PKcs], Ku80 and
Ku70 subunits) is required for CSR (29–32), but the role
of ATM and ATR in CSR has not been determined. ATM
deficiency in humans and mice causes multi-organ pathol-
ogy, including a primary immunodeficiency characterized
by low serum levels of switched antibodies (41–45). Here,
we report that ATM is required for efficient joining of dis-
tal switch regions.
 
Materials and Methods
 
Mice and Immunizations.
 
WT (C57BL/6), ATM
 
 
 
/
 
  
 
(43), Ku80
 
 
 
/
 
 
 
carrying prerearranged heavy and light chains (31), and H2AX
 
 
 
/
 
 
 
(37) mice were bred and maintained under specific pathogen-free
conditions. Age-matched 8–10-wk-old mice were immunized by
footpad injection with 50 
 
 
 
g NP-CGG (Biosearch Technolo-
gies) in complete Freund’s adjuvant. All work with mice was per-
formed under Rockefeller University Institutional Animal Care
and Use Committee–approved protocols.
 
Lymphocyte Cultures and Cell Sorting.
 
B lymphocytes were
isolated from the spleen using CD43 microbeads (Miltenyi Bio-
tec), labeled with 5 
 
 
 
M CFDA-SE for 10 min at 37
 
 
 
C (Molecu-
lar Probes), and cultured (10
 
6 
 
cells/ml) with 25 
 
 
 
g/ml LPS alone
or in combination with 5 ng/ml IL-4 for 5 d. Lymph nodes were
dissected before or after immunization. Germinal center B cells
were stained with APC anti-B220, FITC anti-GL7, and PE anti-
FAS monoclonal antibodies (BD Biosciences). In all cell sorting
experiments, 0.5 
 
 
 
g/ml propidium iodide was added immedi-
ately before laser excitation to exclude dead cells. Cell sorting was
performed on a FACSVantage (Becton Dickinson), and an ali-
quot of each of the sorted fractions was reanalyzed for purity on a
FACSCalibur (Becton Dickinson).
 
Hybridoma Analysis.
 
B cells were stimulated with LPS and
IL-4 for 72 h and fused to the SP2/0Ag-14 myeloma cell line.
IgM-secreting clones were selected by ELISA for further analysis.
Genomic DNA was prepared and Southern blot analysis was per-
formed as described previously (32).
 
PCR, Mutation Analysis, and Quantitative Real-Time RT-PCR.
 
Genomic DNA was amplified by PCR using Pfu Turbo DNA
polymerase (Stratagene) from 5,000 sorted cell equivalents in four
independent reactions that were pooled for cloning experiments.
Total RNA was extracted with TRIzol (Invitrogen) and reverse
transcribed with random hexamers and superscript II reverse
transcriptase (Invitrogen). First strand cDNA was used for SYBR
Green fluorogenic dye real-time PCR (Applied Biosystems).
The primers and PCR conditions that were used have been de-
scribed (32).
 
53BP1 Focus Analysis.
 
After 48 h of stimulation, B cells were
spun onto coverslips and processed for immunocytochemistry-FISH
as described previously (36). Rabbit polyclonal anti-53BP1 antibod-
Figure 1. ATM is required for efficient
CSR, but not for SHM. Flow cytometry analysis
of WT and ATM    B cells stimulated with
LPS plus IL-4 for 4 d (A) or LPS alone (B and
C) for 5 d. Cell division as measured by CFSE
dye dilution is shown on the top. The percent-
age of cells expressing (A) IgG1, (B) IgG2b, and
(C) IgG3 after a specific number of cell divi-
sions is indicated on the bottom. Cells were
stained with Topro-3 before acquisition and
analysis was performed on live B cells (Topro-3 ).
(D) Mutation analysis in the JH4 intron (reference
46) of WT and ATM /  germinal center B cells
(B220  Fas  GL-7 ) obtained from the lymph
nodes of immunized mice. Segment sizes in the
pie charts are proportional to the number of
sequences carrying the number of mutations
indicated in the periphery of the charts. The
frequency of mutations per basepair sequenced
and the total number of independent sequences
analyzed is indicated underneath and in the
center of each chart, respectively. Statistical sig-
nificance was determined by a two-tailed t test
assuming unequal variance and comparing to
WT (P   0.914). Percent nucleotide substitu-
tions adjusted for base composition is shown to
the right of each pie chart. Percentage of muta-
tions within hotspot motifs (references 81–83)
is indicated underneath each panel. The total
number of mutations analyzed was as follows:
WT, 88 mutations/28,120 bp; ATM / , 63
mutations/20,920 bp. 
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ies (provided by J. Chen, Mayo Clinic, Rochester, MN) were used
at a 1:1,000 dilution. The IgH-specific BAC probe spanned from
C
 
 
 
1 to 3
 
  
 
of C
 
  
 
(36).
 
Results
 
ATM Is Required for CSR, But Not SHM.
 
To deter-
mine whether ATM is required for CSR, we stimulated
ATM
 
    
 
and WT B cells in vitro with LPS alone or in
combination with IL-4. Cells were labeled with CFSE to
follow cell division, and CSR was measured by cell surface
expression of IgG1, IgG2b, and IgG3 (Fig. 1, A–C). De-
spite the reported growth defect in ATM
 
 
 
/
 
  
 
mice (42–44),
we found that the rates of cell division and death in
ATM
 
 
 
/
 
  
 
B cells were indistinguishable from WT (Fig. 1
A, top, and not depicted). Nevertheless, ATM
 
    
 
B cells
showed an average threefold reduction of CSR in all three
isotypes analyzed (Fig. 1, A–C, bottom; 
 
n 
 
  
 
7 experi-
ments). We conclude that ATM is required for normal
CSR, but not for B cell proliferation in response to LPS or
LPS and IL-4.
To determine whether ATM is required for SHM, we
immunized ATM
 
 
 
/
 
  
 
and WT control mice with NP-CGG
and cloned and sequenced the J
 
H
 
4 intron (46) from sorted
germinal center B cells (the B220
 
  
 
Fas
 
  
 
GL-7
 
  
 
population).
We found no differences in mutation frequencies (WT:
3.6 
 
  
 
10
 
 
 
3 
 
vs. ATM
 
   
 
: 3.0 
 
  
 
10
 
 
 
3
 
; P 
 
  
 
0.914) or in the
proportion of mutated clones (Fig. 1 D). Furthermore, there
was no significant bias in the nucleotide substitution patterns
found in J
 
H
 
4 sequences cloned from ATM
 
 
 
/
 
  
 
germinal cen-
ter B cells (Fig. 1 D). Thus, ATM is dispensable for SHM.
 
Switch Region Transcription and Mutation.
 
Switch region
transcription plays an essential role in CSR (2, 3). To de-
termine whether ATM deficiency alters switch region tran-
scription, we measured S
 
  
 
and S
 
 
 
1 sterile transcripts in B
cells stimulated with LPS and IL-4 by real-time RT-PCR
(Fig. 2 A). We found that S
 
  
 
and S
 
 
 
1 sterile transcripts
were similar in ATM
 
 
 
/
 
  
 
and control B cells (Fig. 2 A).
However, the IgG1 post-switch transcripts produced by
the circular episomes created by productive CSR (47) were
reduced an average of 2.3-fold in ATM-deficient B cells
(Fig. 2 A; 
 
n 
 
  
 
4 experiments). Thus, although sterile tran-
scription of IgM and IgG1 switch regions is not altered in
the absence of ATM, post-switch transcripts are reduced in
proportion to the reduced frequency of CSR.
DNA sequences located upstream of the Ig switch re-
gions are mutated by an AID-dependent mechanism in B
cells undergoing CSR (32, 36, 48, 49), and these mutations
have been used to measure AID targeting to switch region
DNA. To determine whether ATM is required for S
 
  
 
mu-
tation, we analyzed mutation frequencies in B cells induced
to switch in vitro with LPS and IL-4. The analysis was per-
formed on sorted cells that were IgM
 
  
 
and had completed
five cell divisions. We found similar levels of S
 
  
 
mutation
in ATM
 
 
 
/
 
  
 
and WT B cells (WT: 3.7 
 
  
 
10
 
 
 
4 
 
vs. ATM
 
   
 
:
2.5 
 
  
 
10
 
 
 
4
 
; P 
 
  
 
0.55; Fig. 2 B). We conclude that switch
regions are accessible to and targeted by AID in the absence
of ATM.
 
CSR Junctions.
 
Although CSR is inefficient in the ab-
sence of ATM, some cells do switch to IgG1 in response to
LPS and IL-4 (Fig. 1 A). To determine whether these CSR
junctions are normal, we cloned and sequenced IgG1 CSR
junctions from WT (
 
n 
 
  
 
40) and ATM
 
 
 
/
 
  
 
(
 
n 
 
  
 
32) B cells.
Analysis of the ATM
 
 
 
/
 
  
 
switch junctions revealed no sig-
nificant differences in the extent of donor/acceptor homol-
ogy at the junctions or the average length of overlap (1.9
bp in ATM
 
 
 
/
 
  
 
and 2 bp in controls; Fig. 3 A). The only
notable difference was a slightly lower mutation frequency
in the vicinity of the junctions (
 
  
 
50 bp) in ATM
 
 
 
/
 
  
 
B
cells (WT: 3.2 
 
  
 
10
 
 
 
2 
 
vs. ATM
 
   
 
: 2.0 
 
  
 
10
 
 
 
2
 
; P 
 
  
 
0.01;
Fig. 3 B). We conclude that switch region joining is not
significantly altered in the absence of ATM.
 
Intra-Switch Region Recombination.
 
B cells stimulated to
undergo CSR suffer frequent internal deletions in S
 
  
 
re-
gion DNA (15, 50–52). These deletions are AID depen-
dent (32, 53) and repaired like bona fide CSR through the
nonhomologous end joining pathway (32). To determine
whether ATM is required for this intra-switch region re-
combination, we examined S
 
  
 
and S
 
 
 
1 switch regions
from IgM-expressing hybridomas derived from LPS plus
IL-4–stimulated ATM
 
 
 
/
 
  
 
B cells. By Southern blotting, 11
Figure 2. Switch region accessibility in the absence of ATM. (A) Real-
time RT-PCR for   sterile transcript (  ST),  1 sterile transcript ( 1
ST), and post-switch  1 circle transcript ( 1 CT) in WT (closed bars) and
ATM /  (open bars) B cells stimulated with LPS and IL-4 for 3 d. Mean
results from four independent cultures are expressed as fold induction rel-
ative to WT. (B) Mutations in S  determined in WT and ATM /  B
cells sorted for five cell divisions and expressing IgM. The number of muta-
tions was as follows: WT, 31 mutations/83,773 bp; ATM / , 14 mutations/
55,069 bp. Pie charts are as in Fig. 1. Statistical significance was deter-
mined by a two-tailed t test assuming unequal variance and comparing to
background (resting B cells from WT mice) or WT. P-values are indi-
cated below each pie chart.Class Switch Recombination and Somatic Hypermutation in the Absence of ATM 1106
out of 54 ATM /  hybridomas showed internal deletions
in S  (Fig. 4 A), and only 1 of these also showed an inter-
nal deletion in S 1 (Fig. 4 B). The frequency of internal
deletions in S  (20%) and S 1 (2%) in the ATM /  hy-
bridomas was similar to that found in hybridomas derived
from WT B cells (32). We conclude that in the absence of
ATM, intra-switch recombination proceeds normally. Fur-
thermore, because both intra-switch recombination and
CSR junctions appeared to be normal in ATM /  B cells,
we conclude that switch DNA end joining is not impaired
in the absence of ATM. Consistent with this, ATM /  cells
also support normal DNA end joining in V(D)J recombi-
nation (45, 54, 55).
ATM and DNA Repair Focus Formation. 53BP1 is a
DNA repair factor that like H2AX, is an ATM substrate
(56, 57) and is required for CSR (38, 39). In irradiated
cells, 53BP1 forms H2AX-dependent foci in areas of DNA
damage (37, 58, 59). To determine whether 53BP1 forms
CSR-associated foci and whether these are ATM depen-
dent, we examined B cells undergoing CSR using antibod-
ies to 53BP1 and a DNA probe spanning the IgH locus
(36). After 2 d of stimulation with LPS and IL-4, 18% of B
cells in a given optical section contained at least one 53BP1
focus and a signal from one or both IgH alleles (n   1,028
cells examined). Coincidence of these 53BP1 foci with one
or both IgH alleles was detected in 69% of the cells (n  
185 cells examined; Fig. 5). In contrast, 53BP1 foci were
absent from H2AX /  B cells (n   1,014 cells examined;
Fig. 5), which is in agreement with the observation that
phosphorylation of H2AX is required for 53BP1 focus for-
mation in response to    irradiation (37, 58, 59). Thus,
53BP1 does accumulate at sites of DNA damage during
CSR and this accumulation is H2AX dependent.
To determine whether CSR foci are ATM or DNA-PK
dependent, we assayed for 53BP1 focus formation at the IgH
locus in ATM /  and Ku80 /  B cells. In the absence of
Ku80, the catalytic subunit of DNA-PK is not targeted to
DSBs, leaving the DNA-dependent kinase inactive (60). In
contrast to H2AX /  B cells, ATM /  and Ku80 /  B cells
assembled CSR-associated 53BP1 foci (Fig. 5). The percent-
age of cells containing 53BP1/IgH foci that showed colocal-
ization was 57% in ATM /  B cells (n   1,145 cells exam-
ined) and 66% in Ku80 /  B cells (n   1,273 cells examined).
We conclude that despite the requirement for both ATM and
DNA-PK in CSR, neither of these enzymes is essential for
CSR-associated repair protein focus formation.
Discussion
We found that ATM, a central regulator of the DNA
damage response, is required for efficient CSR. ATM does
not regulate transcription of donor and acceptor switch re-
gions, nor switch region accessibility to AID. It is not
required for DNA repair protein focus formation or intra-
switch region recombination. Analysis of switch recombi-
nation junctions revealed only a small decrease in the mu-
Figure 3. CSR junctions in the absence of
ATM. (A) Histogram depicting the percentage
of sequences with the indicated length of mi-
crohomologies at S /S 1 junctions in WT
(closed bars) and ATM /  (open bars) B cells.
Overlap was determined by identifying the
longest region at the switch junction of perfect
uninterrupted donor/acceptor identity. (B) Muta-
tions in the vicinity of the junctions obtained
from WT and ATM /  B cells. Pie charts are as
in Fig. 1. Statistical significance was determined
by a two-tailed t test assuming unequal variance
and comparing to WT. P-values are indicated
below each pie chart.
Figure 4. Intra-switch region recombination
in the absence of ATM. Southern blot analysis
of (A) S  and (B) S 1 regions in IgM-secreting
hybridomas derived from ATM /  B cells. Re-
striction enzymes and probes used are indicated
in the top panels.  , deletions. Control digests
performed on tail DNA (ATM   ) and the
SP2/0Ag-14 (SP2) fusion partner were loaded
on lanes 1 and 2. The SP2 cell line has a dele-
tion in C  and no hybridization is observed.
The same deletions in S  were found using an
E  probe (not depicted). Number of deletions
over hybridomas screened is indicated below
each panel. Molecular weight markers in kilobase
pairs are indicated on the left side of each panel.Reina-San-Martin et al. 1107
tation frequency in the vicinity of CSR junctions, which
was also found in ATM-deficient human B cells (61).
Therefore, ATM is entirely dispensable for targeting, lesion
formation, and intra-switch region recombination during
CSR. Our results are consistent with a role for ATM in
promoting joining between distant switch regions.
CSR is a deletional recombination reaction with double
strand DNA break intermediates resolved by the non-
homologous end joining DNA repair pathway (29–32).
However, DNA damage in CSR is not limited to DSBs
and is thought to include U:G mismatches, single strand
DNA produced during lesion processing, R loops, and sin-
gle strand nicks (2, 3, 6–8, 21, 62). Although evidence for
the involvement of base excision repair and mismatch re-
pair enzymes in the processing of AID-induced lesions has
been provided (7, 22–27), it remains unclear how DSBs are
generated (28). Single and double strand DNA breaks trig-
ger repair pathways that depend on activation of PIKK ki-
nases ATM and ATR. These kinases recognize DNA dam-
age in conjunction with additional DNA binding proteins:
replication protein A, a single strand DNA binding protein
that recruits ATR (63) and has been implicated in targeting
AID to Ig genes (64), and the complex of Mre11, Rad50,
and Nbs1 (MRN), which is required for maximal activa-
tion of ATM (65). Consistent with the idea that ATM is
dependent on MRN, mutations in Nbs1 or Mre11 pro-
duce human disease phenotypes similar to mutations of
ATM (66–68).
Once activated, PIKK kinases phosphorylate numerous
cellular substrates (40), including histone H2AX and
53BP1 (56, 57, 69–71). H2AX and 53BP1 play important
roles in DSB repair because deletion of either gene leads to
irradiation sensitivity, genomic instability, increased tumor
susceptibility, and a decrease in CSR (32, 36, 37, 72–75).
 -H2AX spreads over megabase domains that flank the
break facilitating DNA repair by remodeling chromatin
and tethering additional repair factors such as MRN and
53BP1 to damaged DNA (76, 77). In the absence of
 -H2AX, these factors recognize and bind damaged DNA,
but they are not retained at the site of DNA damage and do
not appear to spread along the chromosome as evidenced
by lack of DNA damage–associated focus formation (58,
59). Thus, DNA damage–associated chromatin remodeling
is impaired in the absence of H2AX. Aberrant chromatin
remodeling may also account for the specific defect in join-
ing of distant switch regions in the absence of H2AX (32).
We have found that CSR-associated 53BP1 foci are de-
pendent on  -H2AX, but form independently of ATM
and DNA-PK activity. Therefore, during CSR, H2AX
must be phosphorylated by a PIKK kinase with overlapping
specificity, which could be ATM, DNA-PK, or ATR (39).
Indeed, in irradiated fibroblasts, ATM and DNA-PK func-
tion redundantly in  -H2AX focus formation (78). If
 -H2AX is phosphorylated by a redundant kinase and
53BP1 is recruited, why is there a defect in distal switch re-
gion joining in the absence of ATM? One possibility is that
ATM, like DNA-PKcs, has a structural role in CSR in ad-
dition to its catalytic function. DNA-PKcs catalytic mu-
tants have a milder CSR phenotype than complete deletion
of DNA-PKcs (79, 80). A second possibility is that addi-
tional ATM kinase substrates involved in CSR are uniquely
phosphorylated by ATM and are required for switch region
synapsis. In conclusion, ATM deficiency leads to a primary
defect in CSR that may account for the low serum anti-
body levels seen in A-T patients.
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